Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Jesse LoVerme
Synergistic Antinociception by the Cannabinoid Receptor Agonist Anandamide and the PPAR-α Receptor Agonist GW7647
European Journal of Pharmacology
Pharmacology
Related publications
Central Antinociception Induced by Μ-Opioid Receptor Agonist Morphine, but Not Δ- Or Κ-, Is Mediated by Cannabinoid CB1receptor
British Journal of Pharmacology
Pharmacology
Cannabinoid Receptor Type 2 Agonist JWH-133 Deteriorates the Liver Toxicity Induced by Cypermethrin
Turkish Journal of Veterinary and Animal Sciences
Veterinary
Modification of Κ-Opioid Receptor Agonist-Induced Antinociception by Diabetes in the Mouse Brain and Spinal Cord
Journal of Pharmacological Sciences
Molecular Medicine
Pharmacology
Anandamide Transport Inhibition by the Vanilloid Agonist Olvanil
European Journal of Pharmacology
Pharmacology
Radioligand Thermostability Assessment of Agonist-Bound Human Type 2 Cannabinoid Receptor
Biophysical Journal
Biophysics
Prejunctional and Peripheral Effects of the Cannabinoid CB1 Receptor Inverse Agonist Rimonabant (SR 141716)
Naunyn-Schmiedeberg's Archives of Pharmacology
Medicine
Pharmacology
Modulation of Passive Avoidance in Mice by the 5-Ht1a Receptor Agonist Flesinoxan: Comparison With the Benzodiazepine Receptor Agonist Diazepam
Neuropsychopharmacology
Psychiatry
Mental Health
Pharmacology
O-1057, a Potent Water-Soluble Cannabinoid Receptor Agonist With Antinociceptive Properties
British Journal of Pharmacology
Pharmacology
Analysis and Clinical Findings of Cases Positive for the Novel Synthetic Cannabinoid Receptor Agonist MDMB-CHMICA
Clinical Toxicology
Medicine
Toxicology